Alto Neuroscience (ANRO) vs Jade Biosciences (JBIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Alto Neuroscience (ANRO) has outperformed Jade Biosciences (JBIO) over the past year, gaining 296.0% versus a gain of 52.3%. Alto Neuroscience is the larger company by market cap ($942.8 million vs $885.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANRO | JBIO |
|---|---|---|
| Share price | $24.03 | $13.93 |
| Market cap | $942.79M | $885.91M |
| 1-day change | +2.15% | +1.16% |
| YTD return | +32.13% | -10.76% |
| 1-year return | +295.96% | +52.32% |
| 5-year return | — | -97.22% |
| EPS (TTM) | $-2.31 | $-1.92 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $37.48 | $28.00 |
| 52-week low | $5.23 | $8.36 |
| Distance from 52-week high | -35.90% | -50.25% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +59.75% | +259.87% |
| Average volume | 540.09K | 888.66K |
| Shares outstanding | 39.24M | 63.60M |
| Employees | 68 | 55 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ANRO has outperformed JBIO by 243.6 percentage points over the past year.
About Alto Neuroscience
ANRO stock →Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 68 employees
About Jade Biosciences
JBIO stock →Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 55 employees
ANRO vs JBIO FAQ
Which is bigger, Alto Neuroscience or Jade Biosciences?
Alto Neuroscience (ANRO) is larger, with a market capitalization of $942.79M compared with $885.91M for Jade Biosciences (JBIO).
Which stock has performed better over the past year, ANRO or JBIO?
ANRO returned +295.96% over the past 12 months, compared with +52.32% for JBIO (price return, excluding dividends). Past performance does not predict future results.
Are Alto Neuroscience and Jade Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.